FNCH
FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. (FNCH)
$75
About FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. (FNCH)
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Details
Daily high
$12.75
Daily low
$12.75
Price at open
$12.75
52 Week High
$15.85
52 Week Low
$1.27
Market cap
20.5M
Dividend yield
0.00%
Volume
305
Avg. volume
1,054
P/E ratio
-1.45
FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. News
Details
Daily high
$12.75
Daily low
$12.75
Price at open
$12.75
52 Week High
$15.85
52 Week Low
$1.27
Market cap
20.5M
Dividend yield
0.00%
Volume
305
Avg. volume
1,054
P/E ratio
-1.45